Tower Research Capital LLC (TRC) - TRANSMEDICS GROUP INC ownership

TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 1 filers reported holding TRANSMEDICS GROUP INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of TRANSMEDICS GROUP INC
ValueSharesWeighting
Q3 2023$190,420
+157.1%
3,478
+294.3%
0.01%
+200.0%
Q2 2023$74,070
+164500.0%
882
+48.7%
0.00%
+100.0%
Q1 2023$45
-84.1%
593
-87.1%
0.00%
-91.7%
Q4 2022$283
-99.7%
4,588
+76.3%
0.01%
+500.0%
Q3 2022$109,000
+202.8%
2,603
+125.4%
0.00%
+100.0%
Q2 2022$36,000
+300.0%
1,155
+240.7%
0.00%
Q1 2022$9,000
-78.0%
339
-84.5%
0.00%
-100.0%
Q4 2021$41,000
+215.4%
2,182
+437.4%
0.00%
Q3 2021$13,000
-89.3%
406
-88.8%
0.00%
-100.0%
Q2 2021$121,000
-41.3%
3,632
-26.6%
0.00%0.0%
Q1 2021$206,000
+357.8%
4,945
+120.0%
0.00%
+200.0%
Q4 2020$45,000
-84.6%
2,248
-89.4%
0.00%
-66.7%
Q3 2020$293,000
+318.6%
21,235
+445.0%
0.00%0.0%
Q2 2020$70,000
+70.7%
3,896
+15.2%
0.00%
+50.0%
Q1 2020$41,000
+272.7%
3,382
+485.1%
0.00%
+100.0%
Q4 2019$11,000
-87.8%
578
-84.8%
0.00%
-83.3%
Q3 2019$90,000
-52.6%
3,802
-42.0%
0.01%
-53.8%
Q2 2019$190,0006,5510.01%
Other shareholders
TRANSMEDICS GROUP INC shareholders Q4 2023
NameSharesValueWeighting ↓
Roubaix Capital, LLC 264,438$5,027,0004.84%
Abrams Capital Management 3,499,859$66,532,0002.07%
Sandhill Capital Partners LLC 736,175$13,995,0001.55%
EMERALD ADVISERS, LLC 451,542$8,584,0000.36%
RTW INVESTMENTS, LP 503,266$9,567,0000.36%
EMERALD MUTUAL FUND ADVISERS TRUST 429,868$8,172,0000.33%
NEXT CENTURY GROWTH INVESTORS LLC 107,045$2,034,0000.26%
ELEMENT CAPITAL MANAGEMENT LLC 63,175$1,201,0000.26%
HAMILTON LANE ADVISORS LLC 19,364$368,0000.16%
Harbour Capital Advisors, LLC 20,900$397,0000.15%
View complete list of TRANSMEDICS GROUP INC shareholders